BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 1999
View Archived Issues
Company Profile: DeveloGen
Read More
Efficacy of FXR-targeting therapy validated by Symphar-Ilex team
Read More
Faulding acquires anxiety drug from American Home Products
Read More
Positive phase III trial results for OraPharma's periodontal disease treatment
Read More
Cambridge NeuroScience allowed two U.S. patents for GGF2
Read More
Elan to acquire Neuralab and Axogen
Read More
YM-68128: orally active double prodrug of a potent antiplatelet agent
Read More
Sankyo presents new antifungal agent at Japanese symposium
Read More
Team from P&G discovers new use for an old drug
Read More
NMDA antagonists reported to be useful for IBS
Read More
MMP inhibitor NF-681 targets renal cell carcinoma
Read More
Combinations of imidazoles for female genital infections
Read More
Eisai and partner launch Aricept in Japan
Read More
Toyama describes quinolones with particularly high potency against P. acnes
Read More
Indoles from Fujisawa exert both hypoglycemic and PDE-inhibitory effects
Read More
MMP inhibitors in early development at Sankyo
Read More
Potent platelet aggregation inhibitors claimed by Meiji Seika
Read More
Shionogi scientists design new series of HIV integrase inhibitors
Read More
1999 ACAAI news: SC-236 modulates histamine release in in vitro model of allergy
Read More
rhuMAb-E25 may be safely administered during a second pollen season
Read More
Gilead initiates multinational phase III trial of once-daily oral HIV treatment
Read More
First report of efficacy of an antihistamine in vasomotor rhinitis presented at ACAAI meeting
Read More
Eukarion awarded SBIR grant to develop treatment for radiation damage
Read More
Clinical trials commence with T-20 in pediatric HIV infection
Read More
Potent, selective, orally active and nonulcerogenic COX-2 inhibitor identified at Merck Frosst
Read More
SoRI-9409, a potent antinociceptive agent with promising advantages
Read More
Liposomal vinorelbine: design and preliminary characterization in vitro and in vivo
Read More
Interim results from phase II trial of Neotrofin in AD demonstrate safety and effects on memory
Read More
